collaboration
Genomenon, Alexion Pharmaceuticals Team on Rare Disease Dx
Genomenon will apply its AI-driven technology to develop a "genomic landscape" for specific conditions and combine those data with therapy and trial information.
Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle
Oracle and Oxford Nanopore will also collaborate on integrating sequencing data with Oracle's cloud computing infrastructure and life sciences solutions.
Exact Sciences, NSABP Validating Ability of ctDNA Test to Detect MRD in Colorectal Cancer Patients
The study, called CORRECT-MRD II, is expected to enroll approximately 750 patients at 35 study sites in the US and Canada.
Cedars-Sinai, Tempus Partner on Molecular Database Initiative
The partners launched the Molecular Twin initiative to collect cancer patients' DNA, RNA, and protein information and use it to inform treatment and advance research.
Foundation Medicine, Science 37 Partner to Develop Home-Based Clinical Trial Model
Foundation will identify patients that may be eligible for clinical trials, and Science 37 will enroll them and provide ongoing support.